JAMA (Journal of the American Medical Association)
Ir al canal en Telegram
All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
Mostrar más📈 Análisis del canal de Telegram JAMA (Journal of the American Medical Association)
El canal JAMA (Journal of the American Medical Association) (@jamaupdates) en el segmento lingüístico de Inglés es un actor destacado. Actualmente la comunidad reúne a 16 369 suscriptores, ocupando la posición 1 462 en la categoría Medicina y el puesto 2 277 en la región EEUU.
📊 Métricas de audiencia y dinámica
Desde su creación el невідомо, el proyecto ha mostrado un crecimiento acelerado, reuniendo a 16 369 suscriptores.
Según los últimos datos del 15 septiembre, 2026, el canal mantiene una actividad estable. En los últimos 30 días la variación de miembros fue de 316, y en las últimas 24 horas de 15, conservando un alto alcance.
- Estado de verificación: No verificado
- Tasa de interacción (ER): El promedio de interacción de la audiencia es 4.36%. Durante las primeras 24 horas tras publicar, el contenido suele obtener 1.90% de reacciones respecto al total de suscriptores.
- Alcance de las publicaciones: Cada publicación recibe en promedio 713 visualizaciones. En el primer día suele acumular 311 visualizaciones.
- Reacciones e interacción: La audiencia responde de forma activa: el promedio de reacciones por publicación es 1.
- Intereses temáticos: El contenido se centra en temas clave como patient, disease, treatment, drug, guideline.
📝 Descripción y política de contenido
El autor describe el recurso como un espacio para expresar opiniones subjetivas:
“All the latest articles published on JAMA before going in to print
Discussion Group
https://t.me/Medical_Professionals_Forum
Contact us
https://t.me/Contact_Updates_in_Medicine_Bot”
Gracias a la alta frecuencia de actualizaciones (últimos datos recibidos el 16 septiembre, 2026), el canal mantiene la vigencia y un amplio alcance. La analítica demuestra que la audiencia interactúa activamente con el contenido, lo que lo convierte en un punto de referencia dentro de la categoría Medicina.
16 369
Suscriptores
+1524 horas
+767 días
+31630 días
Carga de datos en curso...
Canales Similares
Nube de Etiquetas
Menciones Entrantes y Salientes
---
---
---
---
---
---
Atraer Suscriptores
septiembre '26
septiembre '26
+150
en 0 canales
agosto '26
+361
en 0 canales
Get PRO
julio '26
+440
en 0 canales
Get PRO
junio '26
+422
en 0 canales
Get PRO
mayo '26
+584
en 0 canales
Get PRO
abril '26
+437
en 0 canales
Get PRO
marzo '26
+217
en 0 canales
Get PRO
febrero '26
+247
en 0 canales
Get PRO
enero '26
+321
en 0 canales
Get PRO
diciembre '25
+277
en 0 canales
Get PRO
noviembre '25
+366
en 2 canales
Get PRO
octubre '25
+164
en 0 canales
Get PRO
septiembre '25
+12
en 0 canales
Get PRO
agosto '25
+29
en 0 canales
Get PRO
julio '25
+30
en 0 canales
Get PRO
junio '25
+17
en 0 canales
Get PRO
mayo '25
+9
en 0 canales
Get PRO
abril '25
+5
en 0 canales
Get PRO
marzo '25
+17
en 0 canales
Get PRO
febrero '25
+12
en 0 canales
Get PRO
enero '25
+18
en 1 canales
Get PRO
diciembre '24
+237
en 0 canales
Get PRO
noviembre '24
+1 122
en 0 canales
Get PRO
octubre '24
+1 120
en 0 canales
Get PRO
septiembre '24
+1 527
en 1 canales
Get PRO
agosto '24
+1 128
en 1 canales
Get PRO
julio '24
+1 216
en 0 canales
Get PRO
junio '24
+781
en 1 canales
Get PRO
mayo '24
+797
en 1 canales
Get PRO
abril '24
+808
en 1 canales
Get PRO
marzo '24
+821
en 2 canales
Get PRO
febrero '24
+753
en 1 canales
Get PRO
enero '24
+768
en 0 canales
Get PRO
diciembre '23
+716
en 1 canales
Get PRO
noviembre '23
+96
en 1 canales
Get PRO
octubre '23
+86
en 0 canales
Get PRO
septiembre '23
+73
en 0 canales
Get PRO
agosto '23
+90
en 0 canales
Get PRO
julio '23
+107
en 0 canales
Get PRO
junio '23
+105
en 0 canales
Get PRO
mayo '23
+169
en 0 canales
Get PRO
abril '23
+128
en 0 canales
Get PRO
marzo '23
+84
en 0 canales
Get PRO
febrero '23
+75
en 0 canales
Get PRO
enero '23
+71
en 0 canales
Get PRO
diciembre '22
+74
en 0 canales
Get PRO
noviembre '22
+149
en 0 canales
Get PRO
octubre '22
+90
en 0 canales
Get PRO
septiembre '22
+138
en 0 canales
Get PRO
agosto '22
+77
en 0 canales
Get PRO
julio '22
+50
en 0 canales
Get PRO
junio '22
+96
en 0 canales
Get PRO
mayo '22
+75
en 0 canales
Get PRO
abril '22
+80
en 0 canales
Get PRO
marzo '22
+65
en 0 canales
Get PRO
febrero '22
+26
en 0 canales
Get PRO
enero '22
+56
en 0 canales
Get PRO
diciembre '21
+44
en 0 canales
Get PRO
noviembre '21
+39
en 0 canales
Get PRO
octubre '21
+61
en 0 canales
Get PRO
septiembre '21
+66
en 0 canales
Get PRO
agosto '21
+65
en 0 canales
Get PRO
julio '21
+96
en 0 canales
Get PRO
junio '21
+120
en 0 canales
Get PRO
mayo '21
+130
en 0 canales
Get PRO
abril '21
+812
en 0 canales
| Fecha | Crecimiento de Suscriptores | Menciones | Canales | |
| 16 septiembre | +1 | |||
| 15 septiembre | +15 | |||
| 14 septiembre | +4 | |||
| 13 septiembre | +24 | |||
| 12 septiembre | +9 | |||
| 11 septiembre | +9 | |||
| 10 septiembre | +13 | |||
| 09 septiembre | +4 | |||
| 08 septiembre | +11 | |||
| 07 septiembre | +9 | |||
| 06 septiembre | +16 | |||
| 05 septiembre | +11 | |||
| 04 septiembre | +5 | |||
| 03 septiembre | 0 | |||
| 02 septiembre | +15 | |||
| 01 septiembre | +4 |
Publicaciones del Canal
Caring Collectively Through Palliative Care Partnerships
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2853900
End-of-life cancer care represents a pivotal period for patients, families, and care providers. Palliative care consultation can enhance the quality of end-of-life care for patients with cancer, which has been demonstrated to be beneficial. The palliative care workforce, while growing, is still inadequate to meet patient care needs. Furthermore, the effectiveness of palliative care programs has been inconsistent in prior research, with some programs improving quality of life but not health care utilization. Specifically, hospice utilization varies widely despite the consistent presence of palliative care services in many oncology settings.
| 2 | Administrative Bloat in Neurology and Academic Medicine
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854115
This Viewpoint describes the growth of administrative work across universities, health care, and research and suggests 5 questions a neurology department should ask about any administrative process. | 459 |
| 3 | Clinical Characteristics, Neuroimaging Findings, and Mortality in Korsakoff Syndrome
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854116
This cohort study of French adults diagnosed with Korsakoff syndrome identifies clinical features and outcomes of patients in routine clinical practice and examines factors associated with mortality. | 419 |
| 4 | IVIG in Idiopathic Inflammatory Myopathies
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854117
This randomized clinical trial evaluates the use of intravenous immune globulin as add-on treatment in newly diagnosed idiopathic inflammatory myopathy. | 371 |
| 5 | CAA-Like Brain Imaging and Dural AVF
https://jamanetwork.com/journals/jamaneurology/fullarticle/2854118
This case report describes a patient in their 70s initially diagnosed with cerebral amyloid angiopathy whose diagnosis was challenged with repeat magnetic resonance imaging, which revealed arterialized left temporal cortical vein with an adjacent venous aneurysm. | 360 |
| 6 | Weight Loss in Older Adults With Persistent Atrial Fibrillation
https://jamanetwork.com/journals/jama/fullarticle/2854052
To the Editor In the LOSE-AF randomized clinical trial, a low-calorie diet and behavioral support program achieved significant weight loss but did not improve atrial fibrillation (AF) symptoms, AF burden, or subsequent rhythm-control outcomes in older patients with persistent AF. We believe an imbalance in baseline rhythm-control therapies may have affected the interpretation of these null findings. | 383 |
| 7 | Azithromycin for Cesarean Delivery
https://jamanetwork.com/journals/jama/fullarticle/2854053
Preventing maternal morbidity and mortality remains an urgent global priority, yet progress has been unsatisfactory. Although maternal mortality has declined globally, the rates have increased in the US and infections are among the top causes of preventable deaths. Among women undergoing cesarean delivery (the most common major surgical procedure in the US), the risk of infection is many times higher than after vaginal delivery, underscoring the importance of effective prophylaxis. | 382 |
| 8 | Idiopathic Normal Pressure Hydrocephalus: A Review
https://jamanetwork.com/journals/jama/fullarticle/2854046
This Review discusses the pathophysiology, epidemiology, risk factors, clinical presentation, diagnosis, treatment, and prognosis of idiopathic normal pressure hydrocephalus. | 374 |
| 9 | Error in Results
https://jamanetwork.com/journals/jama/fullarticle/2854054
The Original Investigation titled “Gastric Residual Volume Assessment in Critically Ill Children: The GASTRIC-PICU Randomized Clinical Trial,” published on June 12, 2026, was corrected to update the number of participants in the usual care group in Figure 1 and P values for the intention-to-treat clinical co–primary outcome and per-protocol analysis in the Results section to be consistent with Table 2. This article was corrected online. | 373 |
| 10 | World Trade Center Exposure at 25 Years
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2853739
This Viewpoint discusses how clinicians can screen patients for exposure to the World Trade Center attacks on September 11, 2001. | 657 |
| 11 | Study Finds Artery Damage in Young Adults With CKM Syndrome
https://jamanetwork.com/journals/jama/fullarticle/2854233
Cardiovascular-kidney-metabolic (CKM) syndrome is prevalent among young adults and is associated with greater signs of early artery damage, according to a study published in Circulation: Population Health and Outcomes. Nearly 80% of participants had CKM syndrome stages 1 to 3, which were linked to worse cardiovascular health. | 676 |
| 12 | Nicotine Vapes May Aid in Smoking Cessation
https://jamanetwork.com/journals/jama/fullarticle/2854234
More people may quit smoking when using nicotine e-cigarettes, also known as vapes, compared with conventional nicotine replacement therapies (NRT) such as gum or patches and quitting with or without behavioral support, according to an updated Cochrane review. | 617 |
| 13 | Audio Highlights September 11, 2026
https://jamanetwork.com/journals/jama/fullarticle/2854237
Listen to the JAMA Editor’s Summary for an overview and discussion of the important articles appearing in JAMA. | 571 |
| 14 | Psilocybin
https://jamanetwork.com/journals/jama/fullarticle/2853938
This JAMA Insights discusses the medical use of psilocybin, particularly for depression treatment, including emerging potential indications, safety, and future use. | 726 |
| 15 | Medicine’s Role in Mental Health Promotion
https://jamanetwork.com/journals/jama/fullarticle/2853937
Dana L. Farnsworth, M.D., Cambridge, Mass. | 664 |
| 16 | Loberamisal for Acute Ischemic Stroke Research Summary
https://jamanetwork.com/journals/jama/fullarticle/2854041
This trial evaluated whether intravenous loberamisal improves functional outcomes and is safe in adults with acute ischemic stroke treated within 48 hours of symptom onset. | 627 |
| 17 | Patient Information: Psilocybin
https://jamanetwork.com/journals/jama/fullarticle/2854042
This JAMA Patient Page describes the psychedelic compound psilocybin, its medical and recreational use, and its potential side effects. | 561 |
| 18 | Loberamisal for Acute Ischemic Stroke
https://jamanetwork.com/journals/jama/fullarticle/2854043
This randomized clinical trial evaluates whether intravenous loberamisal improves functional outcomes and maintains an acceptable safety profile in patients with acute ischemic stroke treated within 48 hours of symptom onset. | 520 |
| 19 | Neuroprotective Therapy for Acute Ischemic Stroke
https://jamanetwork.com/journals/jama/fullarticle/2854044
A remarkable era in acute ischemic stroke care is now coming to a close—the period of the “reperfusion revolution.” Over the past few decades, pharmacological and mechanical flow restoration therapies became steadily more effective. By restoring blood flow and terminating the ischemic period, reperfusion salvages those cerebral tissues not yet irreversibly injured. However, the reperfusion strategy in acute stroke care is now reaching its limits. Current endovascular thrombectomy approaches reopen over 85% of occluded arteries, leaving little scope for further advance. And successful reperfusion treatment alone clearly only partially solves the therapeutic challenge. Among patients with ischemic stroke due to large-vessel occlusion who receive endovascular thrombectomy, more than two-thirds nevertheless have a disabled final outcome. Restoring blood flow yields incomplete recoveries because some irreversible injury accrues before recanalization can be achieved and additional injury is generated by reperfusion itself. To fully eradicate stroke-related disability, complementary therapies are needed, including: bridging neuroprotection agents, which allow brain cells to tolerate ischemia until reperfusion is attained; reperfusion neuroprotection agents, which avert reperfusion injury; and neuroreparative agents, which promote postinjury reorganization of neurons and synapses. | 536 |
| 20 | Rheumatoid Arthritis in Adults: A Review
https://jamanetwork.com/journals/jama/fullarticle/2853931
This Review discusses the pathogenesis, epidemiology, risk factors, clinical presentation, diagnosis, treatment, and prognosis of rheumatoid arthritis (RA). | 451 |
